Sherry Brown
Nurse Practitioner · High Springs, FLNPI 1689310559
Payments from drug & device makers
Across 100 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$354
- Johnson & Johnson$216
- Novartis$195
- G1 Therapeutics, Inc.$135
- Jazz Pharmaceuticals Inc.$132
- Takeda Pharmaceuticals U.S.A., Inc.$129
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,30896%
- Education$1084%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 18 | $354 |
| Johnson & Johnson | 7 | $216 |
| Novartis | 8 | $195 |
| G1 Therapeutics, Inc. | 2 | $135 |
| Jazz Pharmaceuticals Inc. | 5 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $129 |
| Myriad Genetic Laboratories, Inc. | 1 | $123 |
| Daiichi Sankyo Inc. | 5 | $98 |
| Bristol Myers Squibb | 4 | $81 |
| Sanofi | 3 | $73 |
| Pfizer | 3 | $68 |
| Amgen | 4 | $62 |
| Gilead | 3 | $62 |
| Karyopharm Therapeutics Inc. | 3 | $60 |
| Bayer | 3 | $58 |
| Genentech USA, Inc. | 3 | $48 |
| Novocure Inc. | 2 | $48 |
| AbbVie | 3 | $48 |
| Rigel Pharmaceuticals, Inc. | 2 | $43 |
| Seagen Inc. | 2 | $41 |
| Merck | 2 | $39 |
| Stemline Therapeutics Inc. | 1 | $33 |
| Octapharma USA, Inc. | 1 | $27 |
| EUSA Pharma (US) LLC | 1 | $25 |
| Sobi, Inc | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Adaptive Biotechnologies Corporation | 1 | $22 |
| Pharmaessentia USA Corporation | 1 | $20 |
| Mirati Therapeutics, Inc. | 1 | $20 |
| Emmaus Medical, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Exelixis Inc. | 1 | $17 |
| Taiho Oncology, Inc. | 1 | $17 |
| EMD Serono, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,416 in reported general payments places this provider in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 21 | $327 |
| Ondansetron OdtOndansetron | 15 | $213 |
| Tamoxifen Citrate | 15 | $200 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in High Springs
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.